Once-Daily Netarsudil Versus Twice-Daily Timolol in Patients With Elevated Intraocular Pressure: The Randomized Phase 3 ROCKET-4 Study

To compare the intraocular pressure (IOP)-lowering efficacy and safety of netarsudil once daily (QD) and timolol twice daily (BID). Double-masked, randomized, phase 3, noninferiority study. Patients with open-angle glaucoma or ocular hypertension (unmedicated baseline IOP >20 to

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:American journal of ophthalmology 2019-08, Vol.204, p.97-104
Hauptverfasser: Khouri, Albert S., Serle, Janet B., Bacharach, Jason, Usner, Dale W., Lewis, Richard A., Braswell, Puiwah, Kopczynski, Casey C., Heah, Theresa, Benza, Robert, Boyle, John W., Butler, Michelle, Cacioppo, Leonard Robert, Cardona, Jose F., Colborn, Valerie A., Day, Douglas G., Douglass, David T., El-Harazi, Sherif M., Ghate, Deepta, Hartman, Carl, Haverly, Robert F., Katzman, Barry, Kim, Max, Koo, Edward Y., Korenfeld, Michael S., Kwapiszeski, Bradley, Lane, Lydia, Lin, Christopher, Logan, Andrew Gardner, Lozier, Jeffrey Raymond, McQuirter, Henry, Mundorf, Thomas K., Olander, Kenneth, Ou, Richard J., Panzo, Gregory J., Peace, James H., Protzko, Eugene E., Ritch, Robert, Sall, Kenneth, Schechter, Barry A., Seltzer, Samuel Eric, Shah, Pankajkumar G., Sharpe, Elizabeth, Lee Shettle, Philip, Shulman, David G., Singh, Inder Paul, Smith, Stacy R., Smith, Stephen E., Smyth-Medina, Robert John, Sorenson, Robert C., Sturm, Richard, Sulkowski, Gregory M., Sutton, James D., Tepedino, Michael, Tsai, Julie, Tubbs, Carl B., Tukel, David B., Walters, Thomas Richard, Wirta, David L.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:To compare the intraocular pressure (IOP)-lowering efficacy and safety of netarsudil once daily (QD) and timolol twice daily (BID). Double-masked, randomized, phase 3, noninferiority study. Patients with open-angle glaucoma or ocular hypertension (unmedicated baseline IOP >20 to
ISSN:0002-9394
1879-1891
DOI:10.1016/j.ajo.2019.03.002